Drug recall · February 7, 2018
BLUE PEARL capsules recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
BLUE PEARL capsules, 500mg, 1-count packets, Distributed by Blue Pearl Long Beach, CA UPC 8 4704600978 5
- Lots / codes
All lots
- Quantity
- 300 pill cards
- Company
- Blue Fusion Natural, Orange, CA
- Distribution
- Nationwide
- Initiated
- November 29, 2017 · Voluntary: Firm initiated
- Classified
- February 1, 2018
- Reported
- February 7, 2018
- Ended
- December 6, 2018
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.